{"keywords":["chemoembolization","cholangiocarcinoma","outcomes","radioembolization"],"publicationTypes":["Journal Article","Review"],"abstract":"Cholangiocarcinoma, whether arising from the intrahepatic or extrahepatic biliary system, is a rare but devastating malignancy. Prognosis is poor, with 5-year overall survival \u003c5% including patients undergoing surgery. Resection is the only curative treatment; however, only âˆ¼30% of patients present at a resectable stage, and intrahepatic recurrence is common even after complete resection. This article discusses the current role of transarterial therapies in the treatment of intrahepatic cholangiocarcinoma. ","title":"Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.","pubmedId":"24436514"}